Tag

pandemic

Managing Innovation and Variability in a Growth Environment
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Managing Innovation and Variability in a Growth Environment

Andrew (Andy) Wirths is a senior pharmaceutical operations leader with over 30 years’ experience in the industry spanning small and large molecule manufacturing.

Andy joined AstraZeneca in 2015 and is currently Senior Vice President, Americas Supply, where he is responsible for overseeing the manufacturing operations of 8 sites in North and South America.

Previously Andy held various senior positions at Merck where he was fundamental to the development of their manufacturing strategy and its execution at multiple sites.

Continue reading
“Applying Lessons Learned from Covid 19 for Future Pandemic Preparedness!”
LIFE SCIENCES, LIFE SCIENCES, VIDEO

“Applying Lessons Learned from Covid 19 for Future Pandemic Preparedness!”

Given the experiences of Covid 19 Pandemic Response, we are even more aware of the need to be ready for what lies ahead with emerging and existing infectious diseases. Covid 19 continues to be a problem with evolving variants, Flu season ahead is anticipated to be worst in years, and we’re learning about new or resurfacing infectious disease outbreaks around the world on a daily basis. Therefore, Pandemic Preparedness is more important now than ever. This presentation will share the key CMC lessons learned from the past two years that can be applied to Pandemic Preparedness – with focus on…

Continue reading
Managing Innovation and Variability in a Growth Environment
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Managing Innovation and Variability in a Growth Environment

How the pandemic impacted the structure and responsiveness of our global networks Responding to new geographic fluctuation of demand by disease states and patient delivery The challenges and opportunities posed by new product innovation and managing lifecycles — Linzell Harris SVP Global Supply Chain and Strategy AstraZeneca Linzell Harris is senior vice president of Global Supply Chain and Strategy for AstraZeneca, with overall responsibility for the development and execution of the end to end supply chain platform and product supply strategies. In addition, he is responsible for ensuring the strategic development of network designs and supply chain capabilities supporting the…

Continue reading
Creating and Maintaining a Resilient Supply Chain: Lessons Learned from a Pandemic
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Creating and Maintaining a Resilient Supply Chain: Lessons Learned from a Pandemic

How do you define a supply chain? The what, the who, the where and the how Risk categorization Impact, probability and detectability Risk approach Detection, prevention/mitigation and response Near-miss lessons learned — Ken Kent SVP, Chemical Development and Manufacturing Operations Gilead Ken is the Senior Vice President of Chemical Development and Manufacturing Operations. He is responsible for Gilead’s entire drug substance supply and oversees process R&D functions in Foster City and Edmonton, as well as internal and outsourced manufacturing. He played a critical role leading CDMO in sourcing ingredients and scaling up production of remdesivir drug substance, to speed up…

Continue reading